This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mcgill University, Novartis Ag. Active years: 2014.
Company Filing History:
1 out of 570 
1 out of 3,975 
Years Active: 2014
Title: Rudolf Schenker: Innovator in Nematode Resistance
Introduction
Rudolf Schenker is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of nematology, particularly in understanding the resistance of nematodes to macrocyclic lactones. His innovative work has implications for animal health and treatment strategies.
Latest Patents
Rudolf Schenker holds 1 patent related to a method for determining the responsiveness of aspp. nematodes to macrocyclic lactones. This invention involves determining the genotype of the nematode at specific positions in a P-glycoprotein gene. The findings indicate that a genotype of GG at certain positions suggests resistance to the macrocyclic lactone. Additionally, the invention outlines methods for selecting appropriate treatments for infected animals and for preventing infections in healthy animals. It also includes an isolated nucleic acid with significant sequence identity to a specified sequence.
Career Highlights
Throughout his career, Rudolf Schenker has worked with prestigious institutions, including the Royal Institution for the Advancement of Learning at McGill University and Novartis AG. His research has contributed to advancements in veterinary medicine and nematode management.
Collaborations
Rudolf has collaborated with notable colleagues such as Roger Prichard and Catherine Bourguinat. Their combined expertise has furthered the understanding of nematode resistance and treatment options.
Conclusion
Rudolf Schenker's innovative work in nematode resistance has paved the way for improved treatment strategies in veterinary medicine. His contributions continue to impact the field significantly.